Others have provided nice arguments as to why this isn't necessarily so, but allow me to add one more that is (I hope) more likely to appeal to a cynic.
This is one area where the corporate focus on short-term profits is actually working to the long-term benefit of humans. While it would be more profitable in the long run to sit on a cure and continue to sell therapeutics indefinitely, what CEO could resist the stock-boosting effect of a cure for a major disease? What a time to exercise your options! Long-term profitability is a problem for the next guy.